HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Yu Selected Research

Amino Acids

1/2021L-Leucine Promotes STAT1 and ISGs Expression in TGEV-Infected IPEC-J2 Cells via mTOR Activation.
1/2019Mathematical models of amino acid panel for assisting diagnosis of children acute leukemia.
1/2018Integrative Genomic and Proteomic Analysis of the Response of Lactobacillus casei Zhang to Glucose Restriction.
1/2018Genomic resequencing combined with quantitative proteomic analyses elucidate the survival mechanisms of Lactobacillus plantarum P-8 in a long-term glucose-limited experiment.
3/2016Comparative Proteomics Analysis Reveals L-Arginine Activates Ethanol Degradation Pathways in HepG2 Cells.
7/2005An HIV-1 tat-autoantigen fusion protein suppresses insulitis in NOD mice.
4/2005The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Yu Research Topics

Disease

188Neoplasms (Cancer)
08/2022 - 01/2002
56Inflammation (Inflammations)
08/2022 - 07/2005
34Infections
01/2022 - 05/2013
33Pain (Aches)
11/2022 - 09/2007
33Hepatocellular Carcinoma (Hepatoma)
08/2022 - 12/2010
33Body Weight (Weight, Body)
07/2022 - 04/2011
32Neoplasm Metastasis (Metastasis)
01/2022 - 10/2005
29Necrosis
06/2022 - 05/2006
19Type 2 Diabetes Mellitus (MODY)
10/2022 - 10/2007
17Diarrhea
12/2021 - 05/2013
16Leukemia
08/2021 - 12/2009
14Carcinogenesis
04/2022 - 12/2003
13Wounds and Injuries (Trauma)
11/2022 - 07/2003
13Hypoxia (Hypoxemia)
05/2022 - 09/2015
13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 09/2013
13Non-alcoholic Fatty Liver Disease
11/2021 - 01/2012
13Fibrosis (Cirrhosis)
10/2021 - 02/2008
13Insulin Resistance
12/2020 - 10/2007
12Seizures (Absence Seizure)
11/2022 - 01/2012
12Neuralgia (Stump Neuralgia)
06/2022 - 06/2013
12Breast Neoplasms (Breast Cancer)
11/2021 - 04/2005
10Hypertension (High Blood Pressure)
08/2022 - 07/2012
10Stroke (Strokes)
01/2022 - 08/2007
9Rhabdomyosarcoma
01/2020 - 05/2006
8Epilepsy (Aura)
11/2022 - 01/2013
8Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 01/2017
8Mitochondrial Diseases (Mitochondrial Disease)
06/2022 - 01/2014
8Myocardial Infarction
01/2022 - 01/2014
8Hemorrhage
06/2021 - 11/2005
8Endometriosis
10/2019 - 09/2007
7Heart Failure
10/2022 - 01/2021
7Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2022 - 07/2005
7Cognitive Dysfunction
07/2022 - 01/2016
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2014
7Birth Weight (Birth Weights)
12/2021 - 10/2012
7Atherosclerosis
12/2021 - 01/2010
7Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 10/2015
7Radiculopathy (Radiculopathy, Cervical)
08/2020 - 10/2010
6Hyperthermia
01/2022 - 03/2016
6Residual Neoplasm
01/2022 - 09/2015
6Lung Neoplasms (Lung Cancer)
11/2021 - 05/2014

Drug/Important Bio-Agent (IBA)

69Proteins (Proteins, Gene)FDA Link
08/2022 - 11/2004
42Messenger RNA (mRNA)IBA
12/2022 - 10/2005
35Pharmaceutical PreparationsIBA
01/2022 - 01/2012
30Biomarkers (Surrogate Marker)IBA
08/2022 - 08/2010
25CytokinesIBA
04/2022 - 11/2006
25Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2011
19LipidsIBA
01/2022 - 05/2006
15Long Noncoding RNAIBA
05/2022 - 01/2017
14DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2003
13MicroRNAs (MicroRNA)IBA
04/2022 - 06/2014
13Therapeutic UsesIBA
01/2022 - 08/2007
12Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 06/2012
12Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 04/2012
12EnzymesIBA
01/2021 - 04/2009
11Interleukin-6 (Interleukin 6)IBA
01/2022 - 07/2008
11AntioxidantsIBA
01/2022 - 09/2007
11Biological ProductsIBA
12/2021 - 06/2014
10Insulin (Novolin)FDA Link
07/2022 - 07/2006
10SodiumIBA
01/2022 - 12/2017
10SaltsIBA
01/2022 - 02/2010
10Triglycerides (Triacylglycerol)IBA
01/2022 - 09/2014
9RNA (Ribonucleic Acid)IBA
11/2022 - 01/2019
9Small Interfering RNA (siRNA)IBA
10/2021 - 01/2015
9AlbuminsIBA
07/2021 - 09/2014
9Antiviral Agents (Antivirals)IBA
01/2021 - 10/2010
8Blood Glucose (Blood Sugar)IBA
07/2022 - 01/2012
8Matrix Metalloproteinases (MMPs)IBA
06/2022 - 06/2012
8NitrogenIBA
04/2022 - 03/2014
8Phosphotransferases (Kinase)IBA
01/2022 - 04/2005
8Liposomes (Liposome)IBA
01/2022 - 10/2005
8Oxygen (Dioxygen)IBA
10/2021 - 03/2008
7Fluorouracil (Carac)FDA LinkGeneric
08/2022 - 05/2015
7Analgesics (Analgesic Drugs)IBA
06/2022 - 02/2014
7Urea (Carbamide)FDA LinkGeneric
04/2022 - 02/2014
7CalciumIBA
01/2022 - 01/2017
7AntigensIBA
01/2022 - 09/2005
7Polysaccharides (Glycans)IBA
07/2021 - 10/2010
7InflammasomesIBA
04/2021 - 03/2017
7Amino AcidsFDA Link
01/2021 - 04/2005
7oxidized low density lipoproteinIBA
06/2020 - 06/2013
7fosbretabulin (combretastatin A4)IBA
01/2020 - 01/2009
7Contrast MediaIBA
01/2020 - 05/2006
6Kainic Acid (Kainate)IBA
11/2022 - 01/2019
6DefensinsIBA
04/2022 - 01/2018
6Indicators and Reagents (Reagents)IBA
01/2022 - 04/2019
6Hemoglobins (Hemoglobin)IBA
01/2022 - 12/2013

Therapy/Procedure

134Therapeutics
12/2022 - 01/2002
49Drug Therapy (Chemotherapy)
08/2022 - 08/2008
12Immunotherapy
01/2022 - 04/2011
11Aftercare (After-Treatment)
05/2022 - 03/2009
11Photothermal Therapy
01/2022 - 02/2010
9Lasers (Laser)
01/2022 - 11/2007
9Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 01/2014
9Precision Medicine
01/2019 - 01/2012
8Radiotherapy
04/2022 - 01/2012
8Ligation
11/2020 - 11/2005
8Transplantation
04/2019 - 07/2003
6Radiofrequency Ablation
11/2022 - 01/2002
6Photochemotherapy (Photodynamic Therapy)
01/2022 - 01/2008